Lv5
1000 积分 2022-02-16 加入
Discovery of RMC-6291, a potent, orally bioavailable, covalent RAS(ON) G12C selective inhibitor
26天前
已完结
Modular Synthesis of Anti-HER2 Dual-Drug Antibody-Drug Conjugates Demonstrating Improved Toxicity
1个月前
已完结
Dual-payload Antibody–drug Conjugates: Taking a Dual Shot
2个月前
已完结
First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial
2个月前
已完结
Piperidine and Azetidine Formation by Direct Cyclization of Diols with N-Nonsubstituted Sulfonamide under the Mitsunobu Conditions Utilizing (Cyanomethylene)tributylphosphorane (CMBP) and Its Application to the Synthesis of Lupinine
2个月前
已完结
Development of an mRNA-based therapeutic vaccine mHTV-03E2 for high-risk HPV-related malignancies
2个月前
已完结
T-cell-engaging bispecific antibodies in cancer
2个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
2个月前
已完结
Deuterium in drug discovery: progress, opportunities and challenges
3个月前
已完结
NVL-330 is a selective, brain-penetrant inhibitor of oncogenic HER2 exon 20 insertion mutations in preclinical models
3个月前
已完结
皖公网安备34019202002308
